Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

D-serine AudRem: R33 Phase

Phase 1

Suspended

Conditions: Schizophrenia
Schizo Affective Disorder

Interventions: Other: Placebo
Drug: D-serine

First Posted Date: 2021-09-16

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 60

Registration Number: NCT05046353

Locations: 🇺🇸
NYSPI, New York, New York, United States

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Phase 2

Recruiting

Conditions: Opioid-use Disorder

Interventions: Drug: Buprenorphine/naloxone
Drug: Placebo

First Posted Date: 2021-08-18

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 180

Registration Number: NCT05011266

Locations: 🇺🇸
Avery Road Treatment Center (ARTC), Rockville, Maryland, United States
🇺🇸
Stars/Nyspi, New York, New York, United States

Cognitive Functioning in Opioid Use Disorder

Not Applicable

Terminated

Conditions: Opioid-use Disorder
Opioid Use
Cognitive Change

First Posted Date: 2021-08-12

Last Posted Date: 2025-03-04

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 13

Registration Number: NCT05001789

Locations: 🇺🇸
NY State Psychiatric Institute, New York, New York, United States

Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer

Phase 3

Suspended

Conditions: Major Depressive Disorder
Breast Cancer
Venlafaxine

Interventions: Drug: Venlafaxine HCl ER
Behavioral: Interpersonal Psychotherapy

First Posted Date: 2021-07-22

Last Posted Date: 2025-05-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 20

Registration Number: NCT04973930

Locations: 🇺🇸
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities

Not Applicable

Completed

Conditions: Opioid-use Disorder

First Posted Date: 2021-07-12

Last Posted Date: 2025-06-29

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 48

Registration Number: NCT04958798

Locations: 🇺🇸
Southcentral Foundation, Anchorage, Alaska, United States
🇺🇸
Native American Community Clinic, Minneapolis, Minnesota, United States
🇺🇸
Missouri Breaks, Eagle Butte, South Dakota, United States

A Study of SPG Block for Opioid Withdrawal

Not Applicable

Suspended

Conditions: Opioid Use Disorder

First Posted Date: 2021-07-01

Last Posted Date: 2023-08-22

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 12

Registration Number: NCT04946656

Locations: 🇺🇸
1051 Riverside Drive, New York, New York, United States

Impact of Telehealth on Engagement in Psychotherapy and/or Medication Treatment

Not Applicable

Terminated

Conditions: Psychiatric Diagnosis

First Posted Date: 2021-06-18

Last Posted Date: 2022-07-28

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 14

Registration Number: NCT04931927

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder

Phase 1

Withdrawn

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Placebo
Drug: Nabilone

First Posted Date: 2021-05-10

Last Posted Date: 2024-05-21

Lead Sponsor: New York State Psychiatric Institute

Registration Number: NCT04880278

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Leveraging Social Networks to Increase COVID-19 Testing Uptake

Not Applicable

Completed

Conditions: Opioid Use
Covid-19
Substance Use

First Posted Date: 2021-05-05

Last Posted Date: 2025-02-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 498

Registration Number: NCT04873401

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

From Hardship to Hope: a Peer-led Intervention to Reduce Financial Hardship and Suicide Risk

Not Applicable

Suspended

Conditions: Suicide
Hope
Suicide Ideation
Suicidal Behavior
Financial Stress

First Posted Date: 2021-04-09

Last Posted Date: 2025-03-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 139

Registration Number: NCT04840134

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy